Arlington, MA, United States of America

Mark Andrew Marchionni

USPTO Granted Patents = 24 


 

Average Co-Inventor Count = 2.4

ph-index = 10

Forward Citations = 336(Granted Patents)


Company Filing History:


Years Active: 1998-2020

Loading Chart...
Loading Chart...
Loading Chart...
24 patents (USPTO):Explore Patents

Title: The Innovations of Mark Andrew Marchionni: A Pioneer in Cardiovascular Research

Introduction: Mark Andrew Marchionni, located in Arlington, MA, is a prominent inventor known for his significant contributions to cardiovascular research. With a remarkable portfolio of 24 patents, Marchionni has focused on advancing methodologies that enhance heart health and treatment options for heart diseases.

Latest Patents: Among his latest innovations, Marchionni has developed methods for cardiomyocyte survival, proliferation, or differentiation using NRG-2. This invention emphasizes therapeutic and diagnostic applications involving NRG-2 polypeptides, nucleic acid molecules, and antibodies, alongside introducing novel NRG-2 polypeptides and nucleic acid compounds. Additionally, he has patented methods for treating congestive heart failure, which utilize a polypeptide featuring an epidermal growth factor-like domain encoded by a neuregulin gene, aiming to improve patient outcomes in heart failure scenarios.

Career Highlights: Throughout his career, Marchionni has made notable impacts within leading organizations in the pharmaceutical and biotechnology sectors. He has contributed to **Acorda Therapeutics, Inc.** and **Cambridge Neuroscience, Inc.**, where he focused on developing innovative therapies that harness the power of molecular biology for heart conditions. His dedication to cardiovascular research has positioned him as a key figure in the field.

Collaborations: Marchionni's work has also involved collaborations with notable individuals in the industry, including coworkers like David I Gwynne and Robert Sklar. These partnerships have been instrumental in fostering cutting-edge research and translating scientific discoveries into practical medical applications.

Conclusion: Mark Andrew Marchionni's pioneering innovations and extensive patent portfolio highlight his commitment to enhancing cardiovascular health through scientific exploration and technological advancement. His work continues to inspire future generations of inventors and researchers dedicated to solving complex health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…